Use of implantable cardioverter-defibrillators for prevention of sudden death in patients at high risk for ventricular arrhythmia.
D001145:Arrhythmias, Cardiac / Q000401:mortality*; D054598:Blue Cross Blue Shield Insurance Plans; D002986:Clinical Trials as Topic; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable / Q000009:adverse effects; D018795:Device Approval; D006801:Humans; D019458:Insurance Coverage; D009203:Myocardial Infarction; D017063:Outcome Assessment, Health Care; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D014481:United States; D014486:United States Food and Drug Administration; D018487:Ventricular Dysfunction, Left